Baiyunshan Pharmaceutical Sets 27 April 2026 Board Meeting to Review Q1 2026 Unaudited Results
Bulletin Express
Apr 14
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited will convene its board of directors on 27 April 2026 to consider and approve the group’s unaudited financial results for the three months ended 31 March 2026. The agenda also allows for the handling of other potential business items.
The current board comprises five executive directors—Li Xiaojun, Chen Jiehui, Cheng Hongjin, Tang Heping and Li Hong—and four independent non-executive directors—Chen Yajin, Huang Min, Wong Lung Tak Patrick and Sun Baoqing.
The announcement was released from Guangzhou on 14 April 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.